Multimedia image tracking enables headache-free HIPAA compliance

SALT LAKE CITY—Novarad, a Utah-based healthcare technology company, will exhibit its latest advancements in universal viewing technology at the Society for Imaging Informatics in Medicine (SIIM) conference and exhibition. This includes the ability to track and monitor the access and usage of not only DICOM, but clinical, non-DICOM multimedia.

“Non-DICOM multimedia is being left on thumb drives and CDs with no method of disaster recovery, no way to keep track of it, and no way to keep it secure,” Paul Shumway, Vice President of the Novarad Corporation said. “HIPAA requires the ability to produce an audit trail. It requires a method of disaster recovery. We want to make that easy for providers. We don’t want that to be what keeps them awake at night.”

The MARZ Patient-Centric Universal Viewer helps providers comply with physical, technical, and administrative requirements by providing secure data storage both on- and off-site, a secondary backup of all patient data, an easily accessible audit trail for clinical multimedia, and system-wide data encryption. For further information regarding these requirements, please refer to sections 164.308 to 164.312 of the HIPAA Administrative Simplification Regulation Text.

The Viewer also allows physicians, nurses and other staff to access and view both DICOM and non-DICOM information on any device through a web browser. For such clinicians, this means they can view diagnostic images, visible light images, labs, reports, and even internet links in the same place.

The SIIM meeting takes place annually and is home to a host of imaging and enterprise IT professionals who meet to learn, share, and network. The conference will take place June 29 – July 1 at the Oregon Convention Center in Portland, Oregon. Novarad will exhibit at booth 505/507. To learn more about Novarad, follow the company on Twitter, @NovaradCorp, or visit www.novarad.net. To learn more about the MARZ Universal viewer, visit novarad.net.

Around the web

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease. 

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care.